JP2021500892A5 - - Google Patents

Download PDF

Info

Publication number
JP2021500892A5
JP2021500892A5 JP2020523340A JP2020523340A JP2021500892A5 JP 2021500892 A5 JP2021500892 A5 JP 2021500892A5 JP 2020523340 A JP2020523340 A JP 2020523340A JP 2020523340 A JP2020523340 A JP 2020523340A JP 2021500892 A5 JP2021500892 A5 JP 2021500892A5
Authority
JP
Japan
Prior art keywords
asparaginase
type
host cells
deficient
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020523340A
Other languages
English (en)
Japanese (ja)
Other versions
JP7358347B2 (ja
JP2021500892A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/056375 external-priority patent/WO2019083794A1/en
Publication of JP2021500892A publication Critical patent/JP2021500892A/ja
Publication of JP2021500892A5 publication Critical patent/JP2021500892A5/ja
Application granted granted Critical
Publication of JP7358347B2 publication Critical patent/JP7358347B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020523340A 2017-10-27 2018-10-17 組み換えE.coliアスパラギナーゼの製造のための方法 Active JP7358347B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762578302P 2017-10-27 2017-10-27
US62/578,302 2017-10-27
PCT/US2018/056375 WO2019083794A1 (en) 2017-10-27 2018-10-17 PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI

Publications (3)

Publication Number Publication Date
JP2021500892A JP2021500892A (ja) 2021-01-14
JP2021500892A5 true JP2021500892A5 (https=) 2021-11-18
JP7358347B2 JP7358347B2 (ja) 2023-10-10

Family

ID=66243528

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020523340A Active JP7358347B2 (ja) 2017-10-27 2018-10-17 組み換えE.coliアスパラギナーゼの製造のための方法

Country Status (7)

Country Link
US (2) US10662433B2 (https=)
EP (1) EP3701036A4 (https=)
JP (1) JP7358347B2 (https=)
CN (1) CN111278979B (https=)
AU (1) AU2018354068C1 (https=)
SG (1) SG11202003614WA (https=)
WO (1) WO2019083794A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019083794A1 (en) * 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク. 組み換えerwiniaアスパラギナーゼの製造のための方法
GB201912020D0 (en) * 2019-08-21 2019-10-02 Porton Biopharma Ltd Therapeutic Conjugate
JP2022553399A (ja) * 2019-10-25 2022-12-22 ジャズ ファーマシューティカルズ アイルランド リミテッド 組換えl-アスパラギナーゼ
CN110904085B (zh) * 2019-12-26 2021-04-16 常州千红生化制药股份有限公司 一种发酵法制备门冬酰胺酶的方法
CN118440925B (zh) * 2023-03-14 2024-12-24 医图生科(苏州)生命科学技术有限公司 一种低免疫原性门冬酰胺酶突变体及其制备方法和应用
WO2025157811A1 (fr) * 2024-01-23 2025-07-31 Asfalia Biologics Promoteurs inductibles par des molecules pharmacologiques

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
GB8519753D0 (en) * 1985-08-06 1985-09-11 Health Lab Service Board Production of 1-asparaginase
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
GB9017002D0 (en) 1990-08-02 1990-09-19 Health Lab Service Board Improved method for the purification of erwina l-asparaginase
US9453251B2 (en) * 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
CA2545610C (en) 2003-11-19 2014-03-25 Dow Global Technolgies Inc. Auxotrophic pseudomonas fluorescens bacteria for recombinant protein expression
AU2004317306B2 (en) 2003-11-21 2010-09-02 Pelican Technology Holdings, Inc. Improved expression systems with Sec-system secretion
US8603824B2 (en) * 2004-07-26 2013-12-10 Pfenex, Inc. Process for improved protein expression by strain engineering
EP2021489A2 (en) 2006-05-30 2009-02-11 Dow Global Technologies Inc. Codon optimization method
MX2009000284A (es) * 2006-06-30 2009-01-26 Enzon Pharmaceuticals Inc Hospedero recombinante para produccion de l-asparaginasa ii.
JP5714230B2 (ja) 2007-01-31 2015-05-07 フェネックス インコーポレイテッド 発現上昇のための細菌リーダー配列
WO2008128975A1 (en) 2007-04-20 2008-10-30 Dsm Ip Assets B.V. Novel asparaginases and uses thereof
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
JP5444553B2 (ja) * 2007-04-27 2014-03-19 フェネックス インコーポレイテッド 微生物宿主を迅速にスクリーニングして、異種タンパク質発現の収率および/または質が改善されている特定の株を同定する方法
WO2011003633A1 (en) 2009-07-06 2011-01-13 Alize Pharma Ii Pegylated l-asparaginase
EP2553102B1 (en) * 2010-03-30 2015-12-09 Pfenex Inc. High level expression of recombinant toxin proteins
CN103060299B (zh) * 2011-10-19 2017-05-03 北京安百胜生物科技有限公司 活性提高的l‑天冬酰胺酶变体
BR102014000585B1 (pt) 2014-01-10 2021-01-12 Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação l-asparaginase recombinante de zymomonas
KR102092225B1 (ko) 2014-04-30 2020-03-23 주식회사 엘지화학 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
JP6817939B2 (ja) 2014-12-01 2021-01-20 フェネックス インク. ペプチド産生のための融合パートナー
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク. 組み換えerwiniaアスパラギナーゼの製造のための方法
WO2019083794A1 (en) * 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI

Similar Documents

Publication Publication Date Title
JP2021500892A5 (https=)
JP2021500896A5 (https=)
CN103403166B (zh) 新的杂合启动子及包含其的重组载体
BR112020006055A2 (pt) moléculas recombinantes de colágeno e elastina e seu uso
PH12020551039A1 (en) Non-viral dna vectors and uses thereof for antibody and fusion protein production
Baeshen et al. Expression and purification of C‐peptide containing insulin using Pichia pastoris expression system
JPWO2018110471A1 (ja) 転写調節融合ポリペプチド
JP2024038140A (ja) ブタトリプシンの変異体
JP5932766B2 (ja) Vps遺伝子が破壊されている酵母を用いる異種タンパク質の製造方法
Chung et al. Highly efficient secretion of heterologous proteins from Saccharomyces cerevisiae using inulinase signal peptides
JPS63289A (ja) バクテリアにおける新規リボゾ−ム結合部位を用いたタンパク生産の増強
US20240197921A1 (en) Signal peptides
Wang et al. Production and characterization of a novel antimicrobial peptide HKABF by Pichia pastoris
Acosta-Rivero et al. Improvement of human interferon HUIFNα2 and HCV core protein expression levels in Escherichia coli but not of HUIFNα8 by using the tRNAAGA/AGG
EA028913B1 (ru) Получение антител высокой чистоты в pichia pastoris
JP2021513330A (ja) ヒトインスリンアナログのコドン最適化前駆体遺伝子およびシグナルペプチド遺伝子
US20160168198A1 (en) Signal sequence for protein expression in pichia pastoris
Frillingos et al. Helix packing in the sucrose permease of Escherichia coli: properties of engineered charge pairs between helixes VII and XI
RU2658758C1 (ru) Рекомбинантная плазмида для экспрессии в дрожжах Pichia pastoris гена химерного белка ангиогенина человека и штамм дрожжей Pichia pastoris - продуцент рекомбинантного химерного белка ангиогенина человека
CN100591758C (zh) 使编码包涵体相关蛋白的ibpA和/或ibpB基因缺失或扩增来制造目标蛋白的方法
JP6943841B2 (ja) メタノール資化性酵母由来新規タンパク質及びそれを用いた目的タンパク質の製造方法
KR102809778B1 (ko) 조절가능한 리보솜 번역 속도를 위한 조성물 및 사용 방법
US8603780B2 (en) Methods and compositions for enhanced expression and secretion of proteins
Egel-Mitani et al. Competitive expression of two heterologous genes inserted into one plasmid in Saccharomyces cerevisiae
Xiong et al. Cloning and expression of rabbit interleukin-15